Goldman Sachs (GS): Rep. Lisa C. McClain (MI09) disclosed a sale $1K–$15K
Rep. Lisa C. McClain (MI09) disclosed a sale of Goldman Sachs in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 21 days
- Disclosure lag
- Traded
- Oct 31, 2025
- Disclosed
- Nov 21, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 23, 2024CongressDisclosed purchase of GS — reported range $1,001 - $15,000
- Jul 24, 2025Congress · 1 personMembers of Congress: 2 sales
- Jul 28, 2025CongressDisclosed sale of GS — reported range $1,001 - $15,000
- Aug 4, 2025CongressDisclosed partial sale of GS — reported range $1,001 - $15,000
- Aug 14, 2025CongressDisclosed partial sale of GS — reported range $1,001 - $15,000
- Sep 11, 2025CongressDisclosed purchase of GS — reported range $1,001 - $15,000
- Oct 10, 2025Congress · 1 personMembers of Congress: 3 purchases
- Oct 14, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
- Oct 31, 2025 · this disclosureCongressDisclosed sale of GS — reported range $1,001 - $15,000
What came next
- Nov 11, 2025CongressDisclosed partial sale of GS — reported range $100,001 - $250,000
- Nov 13, 2025CongressDisclosed partial sale of GS — reported range $1,001 - $15,000
- Nov 17, 2025Government · Federal Register noticeRevisions to the Large Financial Institution Rating System and Framework for the Supervision of Insurance Organizations
- Dec 17, 2025Congress · 1 personMembers of Congress: 2 sales
- Dec 18, 2025Congress · 2 peopleMembers of Congress: 3 sales
- Dec 29, 2025CongressDisclosed purchase of GS — reported range $15,001 - $50,000
- Jan 7, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- Jan 15, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Jan 16, 2026Insider · 1 personInsiders: 37 sales (~$65.8M)
- Jan 23, 2026Insider · 2 peopleInsiders: 22 sales (~$12.8M)
- Feb 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“(b) Kathryn H. Ruemmler has determined to retire from her roles as Chief Legal Officer and General Counsel of The Goldman Sachs Group, Inc., effective June 30, 2026.”
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Goldman Sachs
For Goldman Sachs, OQRO holds 13 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 3 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GS page.
Other recent filings by Rep. Lisa C. McClain (MI09)
- House Clerk periodic transaction report at CACI (CACI)Oct 12, 2026
- House Clerk periodic transaction report at Caterpillar (CAT)Oct 12, 2026
- House Clerk periodic transaction report at Immunitybio (IBRX)Oct 12, 2026
- House Clerk periodic transaction report at Immunitybio (IBRX)Oct 12, 2026
- House Clerk periodic transaction report at Microsoft (MSFT)Oct 12, 2026
The full history of Rep. Lisa C. McClain (MI09) is on the profile page.
How this filing works
Explore the data
Other disclosures at Goldman Sachs
- SEC Form 4Oct 29, 2026
- SEC Form 4Oct 29, 2026
- SEC Form 4Oct 29, 2026
- SEC Form 4Oct 29, 2026
- SEC Form 144Oct 27, 2026
- SEC Form 4Oct 27, 2026
Everything OQRO holds on this company is on its GS page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
